INGDAN (00400) completes the subscription of the second batch of subscribed shares issued under authorization.

03/03/2025

GMT Eight

INGDAN (00400) announced that according to the subscription agreement, the second batch has been completed and implemented on March 3, 2025. After the completion of the second batch, the total number of issued shares of the company has increased from 1.519 billion shares to 1.644 billion shares.

Tianzhi Hang (688277.SH) two shareholders collectively reduced the company's stake by 0.86%.

CH BIOTECH SER(08037) is expected to have a shareholder's net loss of approximately HK$180 million in 2024.

Contact: contact@gmteight.com

INGDAN (00400) completes the subscription of the second batch of subscribed shares issued under authorization.

RECOMMEND

US Stock Market Move | The weight loss drug Cagrisema's clinical trial results did not meet expectations. Novo Nordisk A/S Sponsored ADR Class B (NVO.US) dropped more than 5%.

Asiayang Group (01907) is planning an asset + cash transaction, and may take control of SINOHYTEC (688339.SH,02402) to expand its hydrogen industry chain layout.

Former US Treasury Secretary Mnuchin: Market reaction to Trump administration policies is excessive and unlikely to lead to economic recession.